Aerosol delivery, but not intramuscular injection, of adenovirus-vectored tuberculosis vaccine induces respiratory-mucosal immunity in humans-Reference-Cited by-同舟云学术

Aerosol delivery, but not intramuscular injection, of adenovirus-vectored tuberculosis vaccine induces respiratory-mucosal immunity in humans

Published:2022-02-08 Issue:3 Volume:7 Page:
ISSN:2379-3708
Container-title:JCI Insight
language:en
Short-container-title:

Author:

Jeyanathan Mangalakumari,Fritz Dominik K.,Afkhami Sam,Aguirre Emilio,Howie Karen J.,Zganiacz Anna,Dvorkin-Gheva Anna,Thompson Michael R.^ORCID,Silver Richard F.,Cusack Ruth P.^ORCID,Lichty Brian D.^ORCID,O’Byrne Paul M.,Kolb Martin^ORCID,Medina Maria Fe C.,Dolovich Myrna B.^ORCID,Satia Imran^ORCID,Gauvreau Gail M.^ORCID,Xing Zhou,Smaill Fiona^ORCID

Funder

The Canadian Institutes of Health Research

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://insight.jci.org/articles/view/155655/files/pdf

Reference33 articles.

1. The status of tuberculosis vaccine development

2. New Tuberculosis Vaccine Strategies: Taking Aim at Un-Natural Immunity

3. AdHu5Ag85A Respiratory Mucosal Boost Immunization Enhances Protection against Pulmonary Tuberculosis in BCG-Primed Non-Human Primates

4. Innate immune memory of tissue‐resident macrophages and trained innate immunity: Re‐vamping vaccine concept and strategies

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acidified sucralfate encapsulated chitosan derivative nanoparticles as oral vaccine adjuvant delivery enhancing mucosal and systemic immunity;International Journal of Biological Macromolecules;2024-11

2. Intranasal Immunization with a Recombinant Adenovirus Encoding Multi-Stage Antigens of Mycobacterium tuberculosis Preferentially Elicited CD8+ T Cell Immunity and Conferred a Superior Protection in the Lungs of Mice than Bacillus Calmette–Guerin;Vaccines;2024-09-06

3. A new tool for accelerating tuberculosis vaccine development;The Lancet Infectious Diseases;2024-08

4. Randomised, double-blind, controlled phase 1 trial of the candidate tuberculosis vaccine ChAdOx1-85A delivered by aerosol versus intramuscular route;Journal of Infection;2024-08

5. From pathogenesis to antigens: the key to shaping the future of TB vaccines;Frontiers in Immunology;2024-07-23